|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||
| Net income | ||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||
| Deferred legal expenses | ||||
| Gain on cash (investments) held in Trust Account | ||||
| Change in fair value of derivative warrant liabilities | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses | ||||
| Other current assets | ||||
| Due from related party | ||||
| Accounts payable | ||||
| Due to related party | ||||
| Deferred legal fees | ||||
| Accrued expenses | ||||
| Net cash used in operating activities | ||||
| Cash Flows from Investing Activities | ||||
| Extension contribution deposit into the Trust Account | ||||
| Trust Account withdrawal - redemption | ||||
| Net cash provided by investing activities | ||||
| Cash Flows from Financing Activities | ||||
| Due to related party | ||||
| Proceeds from sale of Private Placement Warrants | ||||
| Proceeds from Promissory note – working capital loan | ||||
| Proceeds from Promissory note – extension loan | ||||
| Redemption of Class A ordinary shares | ||||
| Net cash used in financing activities | ||||
| Net decrease in cash | ||||
| Net decrease in cash | ||||
| Cash - beginning of period | ||||
| Cash - end of period | ||||
| Supplemental disclosure of noncash investing and financing activities: | ||||
| Immediate accretion of Class A shares to redemption value | ||||
| Deferred underwriting fees payable | ||||
| Remeasurement of Class A shares to redemption value | ||||
| Offering costs associated with non-redemption agreement | ||||
| Extension contribution due from Sponsor | ||||
Loading...